Pamela H Lai
Overview
Explore the profile of Pamela H Lai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lancet E, Gonzalez D, Alexandrou N, Zabar B, Lai P, Hall C, et al.
J Am Coll Emerg Physicians Open
. 2021 Mar;
2(2):e12407.
PMID: 33748809
Objective: To determine if oxygen saturation (out-of-hospital SpO2), measured by New York City (NYC) 9-1-1 Emergency Medical Services (EMS), was an independent predictor of coronavirus disease 2019 (COVID-19) in-hospital mortality...
2.
Prezant D, Lancet E, Zeig-Owens R, Lai P, Appel D, Webber M, et al.
J Am Coll Emerg Physicians Open
. 2021 Jan;
1(6):1205-1213.
PMID: 33392524
Objectives: To describe the impact of the COVID-19 pandemic on New York City's (NYC) 9-1-1 emergency medical services (EMS) system and assess the efficacy of pandemic planning to meet increased...
3.
Lai P, Lancet E, Weiden M, Webber M, Zeig-Owens R, Hall C, et al.
JAMA Cardiol
. 2020 Jun;
5(10):1154-1163.
PMID: 32558876
Importance: Risk factors for out-of-hospital death due to novel coronavirus disease 2019 (COVID-19) are poorly defined. From March 1 to April 25, 2020, New York City, New York (NYC), reported...
4.
Lai P, Meng Q, Sielaff T, Hu W
Cell Transplant
. 2005 Sep;
14(6):375-89.
PMID: 16180656
Primary hepatocytes form spheroids under some culture conditions. These spheroids exhibit many tissue-like ultrastructures and retain many liver-specific functions over a long period of time. They are attractive for many...
5.
Lai P, Sielaff T, Hu W
Tissue Eng
. 2005 May;
11(3-4):427-37.
PMID: 15869421
Bioartificial liver (BAL) devices employing xenogeneic hepatocytes are being developed as a temporary support of liver failure. For clinical applications, transporting such a device from the manufacturing site to the...